Boehringer offers selected pre-clinical molecules to scientists worldwide for free via new platform

Boehringer Ingelheim has recently unveiled opnME.com, a centralised platform that allows access to selected pre-clinical molecules from its portfolio for free for non-clinical investigation by international scientists. The German pharmaceutical company hopes that the move will stimulate independent drug discovery and collaborative partnerships worldwide, in addition to the identification of novel treatment solutions for patients.

Continue Reading

New modulator of stem cell identity found by scientists

Since their discovery in 2006, induced pluripotent stem cells provided hope for many diseases. But further research of the complex regulation of pluripotent stem cell identity revealed unexpected difficulties. A team of researchers at the Cluster of Excellence CECAD in Cologne, has now found an efficient way to produce neurons from pluripotent stem cells. As

Continue Reading

Research shows fat cells may render chemotherapeutic drugs inactive

Previous research has shown that obesity is associated with poorer outcomes from several kinds of cancer, including breast, colon, ovarian, and prostate cancers. New research suggests that excess adiposity can affect the “pharmacokinetics” of chemotherapy, or the way drugs are absorbed, metabolised, and excreted from the body. Steven Mittelman, MD, PhD, Associate Professor of Paediatrics

Continue Reading

Scientific research has shown blood-thinners may provide some protection against dementia

Research from the Karolinska Institute has suggested that commonly used blood-thinning drugs for reducing stroke risk in patients with atrial fibrillation (AF) suggests that anticoagulants may also protect patients from dementia. Studies had previously pointed towards a link when looking at 444,106 patients with AF’s records to assess if they could find a clear correlation.

Continue Reading

Ground breaking Artificial Intelligence System has ability to identify 97% of those at risk of breast cancer

Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that has the ability to diagnose patients with breast cancer 97% of the time. The current screening process for breast cancer involves a mammogram and in the event of abnormal cells are identified, a needle biopsy is the next

Continue Reading

KCL scientist uncover how inflammation can affect lifespan of brain cells

Research conducted at King’s College London has revealed how blood inflammation affects the birth and death of brain cells, potentially offering insight for new treatment targets for antidepressants. Mounting evidence points to high levels of inflammation as vital biological abnormality leading to depression in at least one third of patients. Although, the new study offers

Continue Reading

Scientific research by University of York, shows genes are regulated by “Nano footballs”

Research at the University of York found evidence to suggest that genes are controlled by ‘nano footballs’, as the structures bear a strong resemblance to footballs but 10 million times smaller than the average ball. By placing tiny glowing probes on transcription factors, special chemicals inside cells which control whether a gene is switched ‘on’

Continue Reading